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Abstract
Background
Chronic systemic inflammation accelerates early vascular ageing. Atopic sensitization and
allergic diseases may involve increased inflammatory activity. This study aimed to assess
whether atopic sensitization and allergic diseases were associated with altered vascular bio-
markers in Norwegian adolescents.
Methods
Distensibility coefficient of the common carotid arteries, carotid intima-media thickness and
atopic sensitization (serum total and specific IgEs) were assessed in 95 Norwegian adoles-
cents, who participated in the RHINESSA generation study. Symptoms of allergic disease
were assessed by an interviewer-led questionnaire.
Results
Atopic sensitization was found in 33 (34.7%) of the adolescents. Symptomatic allergic dis-
ease was found in 11 (33.3%) of those with atopic sensitization. Distensibility coefficient of
the common carotid arteries appeared to be lower in participants with atopic sensitization
than in those without (46.99±8.07*10−3/kPa versus 51.50±11.46*10−3/kPa; p>0.05), while
carotid intima-media thickness did not differ between these groups (0.50±0.04mm versus
0.50±0.04mm; p>0.05). Crude, as well as age- and sex-adjusted multiple regression,
revealed no significant association, neither of atopic sensitization nor of allergic disease,
with distensibility coefficient of the common carotid arteries and carotid intima-media
thickness.
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Conclusions
Our results do not support the assumption of an adverse impact of atopic sensitization and/
or allergic disease on distensibility coefficient of the common carotid arteries and carotid
intima-media thickness in Norwegian adolescents. Further research is necessary to study
whether the clinical severity of allergic diseases might be more important than the status of
allergic disease or atopic sensitization.
Introduction
Evidence is growing, that inflammatory processes play an important role in atherogenesis, pro-
moting the risk of cardiovascular diseases [1]. Possible pathophysiological links between
inflammation and vascular damage were previously described [2–8]. One of the most investi-
gated mechanisms is the oxidative modification of LDL, which leads to foam cell formation
and development of lesions in the vascular wall [2, 3]. Wang et al. observed a stimulated arte-
rial cell apoptosis and cytokine expression in humans and mice by elevated serum IgE levels
[4]. This might be preceded by decreased serum-levels of low-affinity IgE receptor-positive B
cells, as observed after coronary artery bypass graft surgery [5]. A possible link between
chronic inflammatory activity caused by atopic sensitization and atherosclerosis might be an
elevated activity of mast cells, which leads to multiple effects in the vascular wall, promoting
development and vulnerability of atherosclerotic lesions [6]. The influence of childhood expo-
sure to several pro-inflammatory risk factors on vascular health in adult life has previously
been shown, as well as the relevance of childhood exposure to cardiovascular risk factors for
the later development of atherosclerosis [9–13]. Repeated bacterial or viral infections, obesity
and diabetes mellitus are strong promoters of increased carotid intima-media thickness
(cIMT) in children by means of chronically elevated inflammatory activity [14–16]. So far, a
possible association of chronic systemic inflammation related to atopic sensitization with
cIMT and other biomarkers of early vascular ageing has been analyzed mainly in adult popula-
tions [17, 18]. However, a few studies suggested that allergic diseases might contribute to early
vascular ageing already in early childhood [19, 20].
Atopic sensitization, independent of its clinical penetrance, involves chronic systemic
hyperinflammation. Hence, we hypothesized that atopic sensitization might contribute to
early vascular ageing in young people. The primary aim of this study was to investigate a possi-
ble association of atopic sensitization, independent of its clinical significance, with the disten-
sibility coefficient (DC) of the common carotid arteries and cIMT, which are indicators of
early vascular ageing. Our second aim was to investigate whether the clinical manifestation of
atopic sensitization might be associated with these parameters. Hence, we also analyzed the
association of allergic disease with DC and cIMT.
Methods
Study population
All Norwegian offspring aged 10 to 18 years of ECRHS Bergen participants were invited to par-
ticipate in the prospective RHINESSA generation study (Respiratory Health In Northern
Europe, Spain and Australia, see www.rhinessa.net, Fig 1). Of the 285 offspring 125 had paren-
tal consent for clinical investigation and were screened for eligibility. Exclusion criteria were a
recent operation, an acute infection, diabetes mellitus or other chronic inflammatory diseases
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unrelated to atopy, severe heart disease or pregnancy. Overall, we excluded two candidates
because of diabetes mellitus type 1. Of the remaining 123 participants, 21 had no test of immu-
nological total or specific IgE, because they had not agreed for blood analysis. Furthermore,
seven participants’ ultrasound images did not meet the predefined quality criteria (see S1 and
S2 Files for further details). Therefore, 95 participants were available for main analysis (Fig 1).
Fig 1. Participant recruitment process. �n = 2 with type 1 diabetes mellitus. Further predefined exclusion criteria were
recent operation, an acute infection, diabetes mellitus type 2, any chronic inflammatory diseases unrelated to atopy,
severe heart disease and pregnancy; &No participant´s consent for blood tests.
https://doi.org/10.1371/journal.pone.0220198.g001
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Data analysis was performed in accordance with the Declaration of Helsinki and approved
by the Regional committee for Medical and Health Research Ethics, Western Region (REC
West 2012/1077). Written informed consent was retrieved prior to participation (from parents
if the offspring was below 16 years of age, from the offspring themselves if 16 years or older).
Questionnaires
Extensive information on respiratory health, allergic diseases, general health and environmen-
tal exposures were assessed by a web-based questionnaire, covering all possible covariates for
the analysis: parents’ atopy status, physical activity, frequent exposure to smoking (either active
smoking or exposure to regular parental smoking at home), modality of birth (caesarean sec-
tion versus natural birth) and preterm birth.
An interviewer-led questionnaire before clinical examination assessed respiratory
symptoms during the last months and specifically during the last three days and current medi-
cation. Participants were asked to bring any regular or emergency medication to the study
centers.
Clinical examinations
Based on interview data on hours since having smoked or consumed food and drinks, medica-
tion use, and current infections, no participants were excluded from specific examinations.
Afterwards, we conducted spirometry, FeNO analysis, analysis of total and specific IgE and
anthropometric measures (see S1 File for detailed information).
Main predictors: Atopic sensitization and allergic disease
Atopic sensitization was defined as a positive total or specific IgE towards inhalant allergens
(house dust mite, cat, Timothy (grass, birch, and Cladosporium). Allergic disease was defined
as atopic sensitization plus two of the following clinical criteria: allergic rhinitis, atopic eczema,
food allergy, allergic bronchial asthma or frequent use of doctor-prescribed antihistaminic
medication (see S1 File for further details).
Ultrasonographic examination and main outcomes: DC and cIMT
ECG derived heart rate as well as systolic and diastolic blood pressure were obtained simulta-
neously during the ultrasonographic assessment of DC and cIMT. Blood pressure was mea-
sured on the left upper arm with an OMRON 705 IT-IS Automatic-IS device just before the
examination was started and after ten minutes of rest in a sitting position. The appropriate
cuff size was determined by measuring the upper arm circumference.
The procedure of DC and cIMT measurement was performed by two trained field workers,
using an ultrasound instrument (UF-870, Fukuda Denshi Co. Ltd., Tokyo, Japan) with a LA38
5–16 MHz linear probe. Temporal resolution was 10.47 ms per frame. Data assessment was
conducted using an automated wall-detection software, as previously described and in accor-
dance with current recommendations to ensure acceptable data quality (see S2 File for further
details; [21, 22]). In the pre-study training examinations intraobserver variability was 7.2 and
7.9%, respectively, and, thus, similar to typical values [23]. Interobserver variability was 10.7%
and, thus, slightly higher than previously reported values [23]. Near- and far-wall cIMT as well
as end diastolic and peak systolic outer lumen diameter were obtained from four examination
planes (bilateral common carotid artery horizontal plane and ear-to-ear plane, respectively)
[21]. Afterwards, a mean DC [10−3/kPa] and mean cIMT [mm] were calculated for each par-
ticipant and used for further statistical analysis (see S2 File for further details). Validity,
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reliability and clinical predictive value of DC and cIMT in children and adolescents have been
shown previously [24–27].
Statistical analyses
Data analysis was performed using SPSS version 25.0 for Windows (SPSS Inc., Chicago, Illi-
nois, USA) and R version 3.5.0 for Windows (R Foundation for Statistical Computing, Vienna,
Austria). Descriptive analysis included means, standard deviations (SD), minimum and maxi-
mum values. The level of significance was set at p� 0.05; estimated effects were reported with
95% confidence intervals (95% CI).
Unadjusted (crude) linear regression models, as well as age- and sex-adjusted multiple
regression models were applied to analyze associations of DC and cIMT with atopic sensitiza-
tion and allergic diseases.
Complete data were available for 95 (81.1%) of 117 participants. In the remaining 22 cases
parental or participants´ consent for IgE analyses was not given. We used multiple imputation by
chained equations using the “mice” package in R (version 3.0.3) to impute the missing data [28,
29]. Specifically, we imputed 300 datasets with 10 iterations each. Convergence and distribution
of imputed values were assessed graphically. We applied predictive mean matching for imputation
of continuous variables, logistic regression for binary variables and ordered logistic regression for
ordered categorical variables [30]. The results from the regression models based on the imputed
datasets were pooled using Barnard-Rubin adjusted degrees of freedom for small samples [31].
We repeated all statistical analyses with height-related standard deviation scores (SDS) of
DC and cIMT, because height seems to be a strong determinant for vascular wall properties in
childhood and adolescence [25]. Sensitivity analyses were performed including factors, which
are more or less controversially discussed in literature as possibly being relevant for early vas-
cular ageing and also the risk of atopic sensitization. These factors are current exposure to
smoking (passive and active) [32, 33], physical activity [34], preterm birth [35] and delivery by
caesarean section [36]. None of these additional analyses resulted in significantly different out-
comes and, therefore, they are not presented.
Results
Basic characteristics of the study population
General empiric and vascular characteristic were comparable in participants with and without
atopic sensitization (Table 1). Atopic sensitization was found in 33 (34.7%) of all participants with
available blood samples. Of these participants, allergic disease was found in 11 (33.3%) individuals.
Nine of them took antiallergic medication on a regular basis at the time of examination. Mean
DC was 46.99±8.07�10−3/kPa in the group with atopic sensitization and 51.50±11.46�10−3/kPa in
the group without atopic sensitization. Mean cIMT was 0.50±0.04mm in both groups.
Association of atopic sensitization with biomarkers of early vascular ageing
Neither crude comparison of DC and cIMT, nor the age- and sex-adjusted multivariate regres-
sion model, indicated a significant association of atopic sensitization with these parameters
(Table 2). However, DC tended to be lower in participants with atopic sensitization than in
those without.
Association of allergic disease with biomarkers of early vascular ageing
Neither crude comparison of DC and cIMT, nor the age- and sex-adjusted multivariate regres-
sion model, indicated a significant association of allergic disease with DC and cIMT (Table 2).
Atopy, vascular ageing, adolescents
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Discussion
Mean DC tended to be lower in participants with atopic sensitization than in those without.
However, atopic sensitization revealed no significant association with DC and cIMT in this
study population of Norwegian adolescents. Further, no significant associations of clinically
apparent allergic diseases with DC and cIMT were identified.
In 2015, Evelein et al. found an increased cIMT in five-year old children with several clini-
cal forms of allergies but no changes in arterial distensibility and elasticity [20]. They
Table 1. Population characteristics.
Mean (standard deviation; min/max) / n (%)
Atopic sensitization (n = 33; 34.7%) No atopic sensitization (n = 62; 65.3%) p-value#
Empiric characteristics
Age [years] 15.3 (±1.7; 12.4/18.5) 15.1 (±2.7; 9.8/18.7) ns
Female 16 (48.5%) 32 (51.6%) -
Height [cm] 169 (±9.2; 148/189) 166 (±13.7; 130/188) ns
BMI [kg/m2] 21.4 (±3.3; 16.0/28.7) 21.0 (±4.1; 14.7/38.2) ns
BMI-SDS& [37] 0.58 (±1.23; -1.24/3.27) 0.43 (±1.64; -2.48/6.97) ns
Vascular characteristics
DC [10−3/kPa] 46.99 (±8.07; 28.79/63.97) 51.50 (±11.46; 29.30/95.83) ns
DC-SDS� [25] -0.77 (±0.62; -2.37/0.27) -0.48 (±0.78; -2.51/2.26) ns
cIMT [mm] 0.50 (±0.04; 0.42/0.59) 0.50 (±0.04; 0.42/0.62) ns
cIMT-SDS� [25] 2.30 (±0.88; 0.40/4.19) 2.31 (±0.85; 0.69/4.53) ns
BPsys [mmHg] 108 (±8.1; 92/123) 107 (±8.4; 91/128) ns
BPdia [mmHg] 58 (±4.7; 49/73) 62 (±6.5; 52/90) 0.01
Heart rate [bpm] 68 (±19.2; 48/143) 69 (±18.8; 45/170) ns
BMI = Body mass index; BMI-SDS = Standard deviation score of BMI; DC = Distensibility coefficient of the common carotid arteries; DC-SDS = Standard deviation
score of DC; cIMT = Carotid intima-media thickness; cIMT-SDS = Standard deviation score of cIMT; BPsys = Blood pressure, systolic; BPdia = Blood pressure, diastolic.
#T-test derived differences between subpopulations with and without atopic sensitization were considered significant, if two-tailed p � 0.05 (ns = p > 0.05).
&Norwegian reference population.
�Mainly European reference population.
https://doi.org/10.1371/journal.pone.0220198.t001
Table 2. Multiple linear regression analysis of associations of atopic sensitization and allergic disease with DC and cIMT.
Model β lower 95% CI upper 95% CI p
Atopic sensitization& DC crude -3.10 -8.80 2.60 0.28
DC adjusted� -3.04 -7.99 1.90 0.22
cIMT crude 0.004 -0.01 0.02 0.66
cIMT adjusted� 0.004 -0.01 0.02 0.67
Allergic disease# DC crude -1.94 -10.42 6.53 0.64
DC adjusted� -1.01 -8.89 6.87 0.80
cIMT crude 0.009 -0.02 0.04 0.54
cIMT adjusted� 0.008 -0.02 0.04 0.60
&Atopic sensitization = any positive total or specific IgE in the serological analyses (dermatophagoides, cat, birch, timothy grass, cladosporium)
#Allergic disease = atopic sensitization plus two of the following clinical criteria: allergic rhinitis, atopic eczema, food allergy, allergic bronchial asthma or frequent use of
doctor-prescribed antihistaminic medication
�Models adjusted for age and sex. DC = Distensibility coefficient of the common carotid arteries; cIMT = Carotid intima-media thickness; β = Estimated effect;
CI = Confidence interval; level of significance set at p � 0.05.
https://doi.org/10.1371/journal.pone.0220198.t002
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concluded that allergies are associated with arterial changes in young children. However, our
data do not support their cIMT findings. Possibly, age as well as timing and severity of clinical
manifestations of atopy might play a role. Yet, the tendency towards a lower DC in our partici-
pants with atopic sensitization might be a very early sign for a chronic subclinical impact of
atopic sensitization on vascular ageing. Helpful markers of the severity of systemic inflamma-
tory activity (i. e. oxLDL, high-sensitivity C-reactive protein, soluble interleukin-2 receptor,
eosinophil cationic protein) were not available in both studies. However, we analyzed total and
specific IgE, which are valid markers for qualitative assessment of atopic sensitization but do
not give information about the severity of systemic inflammatory activity [38]. We assume that
the inflammatory activity in our study population might have been somewhat heterogeneous,
which would explain the lack of association of atopic status and allergic disease with DC and
cIMT. Whether the strength of such an association might depend on the severity of systemic
inflammatory activity needs to be investigated in larger prospective studies including more
information about current and cumulative lifetime systemic inflammatory activity.
Another study found an adverse influence of repeated episodes of common childhood
infectious diseases on cIMT [15]. This has also been suspected by Liuba et al. in 2005 [9]. Their
multiple hit theory states that repeated episodes of acute infections might enhance oxidized
modification of LDL, which plays an important role in the development of atherosclerosis by
fostering foam cell accumulation and subsequent thickening of the vascular wall [39, 40]. This
association of inflammation and formation of atherogenic oxidized LDL (oxLDL) has been
described in autoimmune disorders as well and a comparable pathomechanism is imaginable
in allergic diseases [2, 3]. Acute allergic reactions cause IgE-triggered mast cell activation and
an acute-phase reaction, both leading to increased oxidative stress [2, 18, 41]. Activated mast
cells degranulate cytokines, leukotrienes, prostaglandins and histamine, leading to endothelial
activation and facilitated intracellular penetration of LDL [41]. Endothelial oxidative modifica-
tion of LDL might be enhanced in children with allergic diseases, due to increased oxidative
stress and decreased antioxidative capacity [2, 42]. Furthermore, several authors suggested that
IgE-triggered mast cell activation during acute allergic reactions might lead to facilitated pre-
sentation of LDL to macrophages subsequently enhancing formation of foam cells [43, 44]. It
was also suggested, that atherogenic complexes of CRP and oxLDL with or without β2-glyco-
protein-I might be present during acute phase reactions [2, 3, 45, 46]. Accordingly, the severity
of clinical penetrance of atopic sensitization in terms of cumulative lifetime load of number
and severity of allergic bouts might be a key factor to produce a relevant atopy-associated effect
on vascular ageing. The results of our analyses on participants with allergic diseases do not
support this hypothesis. However, we did not have information about the severity of past clini-
cal allergic episodes in our participants and the lifetime load of antiallergic treatment. Yet, clar-
ification of this question might be of importance for clinicians, as they would be encouraged to
control allergic diseases very carefully in order to avoid adverse effects on long-term vascular
health in affected children and adolescents. Future studies should therefore obtain detailed
information about the number and severity of acute clinical exacerbations of allergic diseases
of their participants in the past and address this question. Finally, it would be intriguing to
compare the levels of oxLDL during chronic and acute hyperinflammatory activity in atopic
children and adolescents and investigate their association with accelerated arterial stiffening
and increased intima-media thickness.
Strengths and limitations
The standardized, high-quality measurements of DC and cIMT in a cohort of adolescents was
a main strength of our study. Although early structural changes due to chronic systemic
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inflammation have been reported in children and adolescents [15, 20, 47], one should be
aware, that the assessment of functional instead of structural alterations (e.g. by flow-mediated
dilation), might lead to earlier detection of increased vascular risk related to atopic sensitiza-
tion. Furthermore, our study does not allow establishing causality, due to its cross-sectional
nature. Yet, there was a tendency towards an association of atopic sensitization with decreased
DC and the non-significance of the results might be, at least in part, due to the relatively small
sample size. We performed analysis of total and specific IgE, which are qualitative markers of
the degree of atopic sensitization on the immunological level [38]. Further, based on interview
and clinical measurements, our cohort had a relatively thorough phenotyping with regard to
allergy. Further detail about the number and severity of clinical episodes of allergic disease,
earlier medical treatment and assessment of further inflammatory markers (i. e. oxLDL, high-
sensitivity C-reactive protein, soluble interleukin-2 receptor, eosinophil cationic protein)
would have been helpful for a characterization of the lifetime load of hyperinflammatory activ-
ity in our study population. This may be especially relevant, as the relatively small number of
participants with symptomatic allergic disease might be a major limiting factor for the non-sig-
nificance of our results. Future studies should aim towards a detailed characterization of the
extent and severity of inflammatory activity in their participants, as well as a larger sample
size. A selection bias due to the exclusion of the 21 participants, due to denied parental consent
for blood tests, seems also very unlikely, as their empirical, vascular and clinical allergy charac-
teristics were not different from those included in the study.
Conclusions and perspectives
To the best of our knowledge, this study is the first to analyze a possible association of atopic
sensitization and allergic diseases with DC and cIMT in adolescents. Whereas evidence points
towards an impact of systemic hyper-inflammation due to atopic sensitization on the vascular
endothelium, our results do not support this assumption in adolescents [2, 3, 9, 15, 20, 39].
Better knowledge about the impact of the clinical character, main determinants and potential
role of disease control of either atopic sensitization or allergic diseases might be valuable. Fur-
ther studies should investigate, whether the number and severity of repeated acute clinical
bouts of allergic diseases might be a predictor of early vascular ageing, rather than chronic
low-grade inflammatory activity mediated by atopic sensitization.
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